FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines

Cancer Research

Volumn 57, Issue 11, 1997, Pages 2112-2115

  Hendricks, Denver T ^a,c   Taylor, Robert ^b   Reed, Mark ^b   Birrer, Michael J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c Oncol Res Fac Development Program

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL; CELL MIGRATION; CYTOGENETICS; DNA SEQUENCE; ENDOMETRIUM CANCER; EPITHELIUM CELL; EXON; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ACID ANHYDRIDE HYDROLASES; BLOTTING, SOUTHERN; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; PROTEINS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0030912964     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statisties, 1996. CA-Cancer J. Clin., 46: 5-27, 1996.
2. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili. Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
3. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, S., De Gregorio, L., Pastorino, U., Pierotti, M. A., Ohta, M., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell, 85: 17-26, 1996.
4. Sozzi, G., Alder, H., Tornielli, S., Corletto, V., Baffa, R., Veronese, M. L., Negrini, M., Pilotti, S., Pierotti, M. A., Huebner, K., and Croce, C. M. Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res., 56: 2472-2474, 1996.
5. Virgilio, L., Shuster, M., Gollin, S. M., Veronese, M. L., Ohta, M., Huebner, K., and Croce, C. M. FHIT gene alterations in head and neck squamous cell carcinomas. Proc. Natl. Acad. Sci. USA, 93: 9770-9775, 1996.
6. Jones, M. H., and Nakamura, Y. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. Oncogene, 7: 1631-1634, 1992.
7. Chung, G. T., Huang, D. P., Lo, K. W., Chan, M. K., and Wong, F. W. Genetic lesion in the carcinogenesis of cervical cancer. Anticancer Res., 12: 1485-1490, 1992.
8. Ehlen, T., and DuBeau, L. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. Oncogene, 5: 219-223, 1990.
9. Szabo, E., Pries, L. H., Brown, P. H., and Birrer, M. J. The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation. Cell & Growth Differ., 2: 474-482, 1991.
10. Thiagalingam, S., Lisitsyn, N. A., Hamaguchi, M., Wigler, M. H., Wilson, J. K. V., Markowitz, S. D., Leach, F. S., Kinzler, K., and Vogelstein, B. Evaluation of the FHIT gene in colorectal cancers. Cancer Res., 56: 2936-2939, 1996.
11. Panagopoulos, I., Pandis, N., Thelin, S., Petersson, C., Mertens, F., Borg, A., Kristoffersson, U., Mitelman, F., and Åman, P. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements in chromosome band 3p14. Cancer Res., 56: 4871-4875, 1996.
12. Mao, L., Fan, Y-H., Lotan, R. and Hong, W. K. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res., 56: 5128-5231, 1996.
13. Boldog, F., Gemmill, R. M., West, J., Robinson, M., Robinson, L., Li, E., Roche, J., Todd, S., Waggoner, B., Lundstrom, R., Jacobson, J., Mullokandov, M. R., Klinger, H., and Drabkin, H. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum. Mol. Genet., 6: 193-203, 1997.
14. Druck, T., Hadaczek, P., Fu, T., Ohta, M., Siprashvili, Z., Baffa, R., Negrini, M., Kastury, K., Veronese, M. L., Rosen, D., Rothstein, J., McCue, P., Cotticelli, M. G., Inoue, H., Croce, C. M., and Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57: 504-512, 1997.
15. Barnes, L. D., Garrison, P. N., Siprashvili, Z., Guranowski, A., Robinson, A. K., Ingram, S. W., Croce, C. M., Masataka, O., and Huebner, K. FHIT, a putative tumor suppressor in humans, is a dinucleoside 5′,5‴-triphosphate hydrolase. Biochemistry, 35: 11529-11535, 1996.